FindTrial
Sign In

A study to see the effect of Rasonadi churn in a menstrual cycle where no egg is released

A randomised controlled clinical trial to evaluate the effect of Rasonadi churn in the management of Anovulatory cycle. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/087326
Enrollment
35
Registered
2025-05-21
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N970- Female infertility associated withanovulation

Interventions

None listed

Sponsors

Aarti Ramesh Jadhav
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1-All prediagnosed patients having anovulatory cycle or unruptured ovarian follicle. 2-Married patients 3-Patients having may or may not be associated with PCOS pattern,scanty,regular,irreregular menses

Exclusion criteria

Exclusion criteria: 1-Patients with Chronic systemic diseases like Diabetes 2-Patients suffering from disoreders of reproductive tract like congenitaldeformities,suspected cases of CA cervix etc 3-Patients with HIV,HbsAg,VDRL positive 4-Uterine synchiae ,uterine fibriods etc. 5-Endometriosis 6-Endometrial carcinoma.

Design outcomes

Primary

MeasureTime frame
Rupture of follicleTimepoint: 8week—

Secondary

MeasureTime frame
1-Folliclar size 2-regularity of mensesTimepoint: 8week—

Countries

India

Contacts

Public ContactDr Rutuja Sandeep Gaikwad

R.A.Podar Medical College (Ayu.)Worli

drrutujasg@gmail.com9699825626

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026